ISSN: 1750-1911

Journal Home

Journal Guideline

Epigenomics Q3 Unclaimed

Taylor and Francis Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Epigenomics is a journal indexed in SJR in Genetics and Cancer Research with an H index of 82. It has a price of 2395 €. It has an SJR impact factor of 0,69 and it has a best quartile of Q3. It has an SJR impact factor of 0,69.

Epigenomics focuses its scope in these topics and keywords: dna, epigenome, methylation, peripheral, associations, basis, bloodderived, cancer, cancera, cancermodeling, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q3) Genetics (Q3)

Price

2395 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,69

SJR Impact factor

82

H Index

104

Total Docs (Last Year)

366

Total Docs (3 years)

6938

Total Refs

784

Total Cites (3 years)

326

Citable Docs (3 years)

1.97

Cites/Doc (2 years)

66.71

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Cancer genetics Q3
BMC Medical Genomics Q3
Current Stem Cell Reports Q3
Molecular Genetics and Metabolism Reports Q3
neurogenetics Q3

Compare this journals

Aims and Scope

Best articles by citations

DNA methylation, insulin resistance and second-generation antipsychotics in bipolar disorder

Long noncoding RNAs: versatile players in biologcial processes and human disorders

The role of epigenetics in tuberculosis infection

Current methylation screening methods

Institutional Profile: The Einstein Center for Epigenomics: studying the role of epigenomic dysregulation in human disease

AID and APOBEC deaminases: balancing DNA damage in epigenetics and immunity

Methadone induces hypermethylation of human DNA

Pediatric cancer epigenome and the influence of folate

The DNA sequencing renaissance and its implications for epigenomics

New hypotheses for large-scale epigenome alterations in somatic cancer cells: a role for male germ-cell-specific regulators

Epigenetic architecture and miRNA: reciprocal regulators

Histone deacetylase inhibitors in the therapy of cancer: much to learn

SHOW MORE ARTICLES

Circulating miRNAs as intercellular messengers, potential biomarkers and therapeutic targets for Type 2 diabetes

The application of genome-wide 5-hydroxymethylcytosine studies in cancer research

Research Highlights

Integrated analysis of genetic and epigenetic alterations in cancer

Uncovering combinatorial interactions in chromatin

Epigenetic control of inducible gene expression in the immune system

Epigenetic dysregulation in follicular lymphoma

Epigenetic epidemiology: is there cause for optimism?

Research Highlights: Nutritional status affects the epigenomic profile of peripheral blood cells

Polycomb group-mediated gene silencing mechanisms: stability versus flexibility

Pharmacoepigenomic responses of antipsychotic drugs on pharmacogenes are likely to be modulated by miRNAs